As the dust settles on its successful takeover of Awakn Life Sciences, investors are starting to appreciate the potential of ...

Canada-based PharmaTher has received US Food and Drug Administration (FDA) approval for its ketamine therapy for surgical ...

Discover six of the top psychedelic companies developing novel drugs to expand the treatment scope for mental health ...

John C. Reed, Executive Vice President, Innovative Medicine and R&D of Johnson & Johnson( JNJ 0.35%), executed an open market sale of 19,137 shares as disclosed in a Form 4 filed July 18, 2025.

The psychedelic pharmaceutical sector continues gaining mainstream acceptance as regulatory barriers fall and medical ...

Health is growing its impact in Sioux Falls and surrounding communities with a newly expanded clinic and, soon, another ...

PharmaTher Holdings Ltd. (the 'Company” or 'PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company focused on unlocking the pharmaceutical potential of ketamine, is pleased to ...

HOPE & NRx Pharma receive final clearance from Florida's AHCA to proceed to closing of Dura Medical acquisition: Miami Monday, August 11, 2025, 13:00 Hrs [IST] HOPE Therapeutics, ...

NRx Pharmaceuticals (NASDAQ: NRXP), through its wholly owned subsidiary HOPE Therapeutics (TM), Inc., announced it has ...

Relief Mental Health is proud to announce that David Krasnov, PMHNP‑BC has joined its award‑winning Red Bank team in New ...

Relief Mental Health is proud to announce that David Krasnov, PMHNP‑BC has joined its award‑winning Red Bank team in New ...

PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the "Company" or "PharmaTher"), a specialty pharmaceutical company focused on unlocking the ...